Delivery Order SPE2DB25D3017-SPE2DB25FVHPJ
- Not listed
- This is a federal delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The contract has a ceiling value of $16,364.93 and is for the delivery of the prescription medication Gralise ER 600 mg tablets. The contract is a Firm Fixed Price contract with a completion date of May 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the Defense Logistics...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of Gralise ER 600 mg tablets, a prescription medication, and has a ceiling value of $34,639.51. The contract is a firm fixed price delivery order with a performance period through March 13, 2024. AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract, with a ceiling value of $2,359.80, is for the delivery of the pharmaceutical product Gralise ER 600 mg tablets. The contract is a firm fixed-price Delivery Order with a completion date of February 27, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Gralise ER 600 mg tablets (90-count) with a ceiling value of $3,305.61. The delivery order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical, is scheduled for completion by December 16, 2025. This non-set-aside award was made competitively through the federal...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,783.79, is for the delivery of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of November 15, 2023. AmerisourceBergen holds a significant...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a ceiling value of $2,630.61 and is for the delivery of the pharmaceutical product Gralise ER 300 mg Tablet 90s. Amerisourcebergen Drug Corp, as the prime contractor, is responsible for providing this medication and other pharmaceutical and medical supplies to support military...
- The Defense Logistics Agency awarded a $7,157.24 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Gralise ER 300 mg tablets (90-count units). This contract represents a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $14,657.33 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of GRALISE ER 600 MG tablets. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of GRALISE ER 600 MG TABLET 90S. The contract has a ceiling value of $24,721.70 and a period of performance running through January 29, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the drug GRALISE ER 600 MG TABLET 90S to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,140.50, has an ultimate completion date of September 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVHPJDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Gralise ER 600 mg tablets. The contract has a ceiling value of $1,029.03 and a period of performance through April 4, 2025. The contract is a firm-fixed price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely one of many placed under the larger IDC to support military and government healthcare programs by supplying a range of pharmaceutical products and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 4/3/25 |